Article
Unveiling the role of TLR9 promoter variants in susceptibility and clinical features of systemic lupus erythematosus.
Lupus - 1 Sept 2026
Soleimani Fatemeh, Karbalaei-Musa Hamidreza, Hajali Mohammad Hossein, Kenarangi Taiebe, Mosallaei Meysam, Ansari Narges
Abstract excerpt
ObjectiveSystemic lupus erythematosus (SLE) is a multifactorial autoimmune disease in which dysregulated nucleic acid sensing and type I interferon responses drive autoantibody production and organ damage. Toll-like receptor 9 (TLR9) regulates these pathways, and promoter variants (rs187084 and rs5743836) may alter TLR9 expression and modulate disease susceptibility and severity. This study evaluated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
